Author

Irene Guimerans-Lorenzo

Observed institution: Janssen (Belgium)

ORCID: 0009-0000-6030-6085

Observed ORCID: 0009-0000-6030-6085

OpenAlex ID: A5115022940

JNJ-87801493 (CD20xCD28), a Potential First-in-Class CD20 Targeted CD28 Costimulatory Bispecific Antibody, Enhances the Activity of B-Cell Targeting T-Cell Engagers in Preclinical Models

2024 · Lorena Fontan, Adam Zwolak, et al. · Blood · 3

Preclinical characterization of the potent and selective MALT1 inhibitor safimaltib in B-cell lymphoma models

2026 · Ulrike Philippar, Lorena Fontan, et al. · Blood Cancer Discovery

Works count: 2

Citation count: 3

H-index: 1

I10-index: